Answers are grounded in this paper and cite their sources.
The 340B Program has been associated with hospital-physician consolidation in hematology-oncology and with more hospital-based administration of parenteral drugs in hematology-oncology and ophthalmology. Financial gains for hospitals have not been associated with clear evidence of expanded care or lower mortality among low-income patients. (Funded by the Agency for Healthcare Research and Quality and others.).
No takes yet. Share an insight, caveat, or question.
Desai et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: